| 1. | Chambers HF. The changing epidemiology of Staphylococcus aureus? [J]. Emerg Infect Dis, 2001; 7(2): 178-182. | 
				                                                        
				                                                            
				                                                                | 2. | 汪復, 朱德妹, 胡付品, 等. 2008年中國CHINET細菌耐藥性監測 [J]. 中國感染與化療雜志, 2009; 9(5): 321-329. | 
				                                                        
				                                                            
				                                                                | 3. | 朱德妹, 汪復, 張嬰元. 2004年上海地區細菌耐藥性監測 [J]. 中國抗感染化療雜志, 2005; 5(4): 195-200. | 
				                                                        
				                                                            
				                                                                | 4. | 朱德妹, 張嬰元, 汪復. 2006年上海地區細菌耐藥性監測 [J]. 中國感染與化療雜志, 2007; 7(6): 393-399. | 
				                                                        
				                                                            
				                                                                | 5. | Hope R, Livermore DM, Brick G, et al. Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06 [J]. J Antimicrob Chemother, 2008; 62 Suppl 2: ii65-ii74. | 
				                                                        
				                                                            
				                                                                | 6. | 王琳, 時萍, 丁海燕, 等. 157株MRSA菌株的耐藥調查及感染病例的用藥分析 [J]. 抗感染藥學, 2005; 2(3): 121-122, 127. | 
				                                                        
				                                                            
				                                                                | 7. | Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania [J]. Antimicrob Agents Chemother, 2004; 48(1): 275-280. | 
				                                                        
				                                                            
				                                                                | 8. | Sibbald MJ, Ziebandt AK, Engelmann S, et al. Mapping the pathways to staphylococcal pathogenesis by comparative secretomics [J]. Microbiol Mol Biol Rev, 2006; 70(3): 755-788. | 
				                                                        
				                                                            
				                                                                | 9. | Noto MJ, Archer GL. A subset of Staphylococcus aureus strains harboring staphylococcal cassette chromosome mec (SCCmec) type Ⅳ is deficient in CcrAB-mediated SCCmec excision [J]. Antimicrob Agents Chemother, 2006; 50(8): 2782-2788. | 
				                                                        
				                                                            
				                                                                | 10. | Berger-Bchi B, Strssle A, Gustafson JE, et al. Mapping and characterization of multiple chromosomal factors involved in methicillin resistance in Staphylococcus aureus [J]. Antimicrob Agents Chemother, 1992; 36(7): 1367-1373. | 
				                                                        
				                                                            
				                                                                | 11. | 李松, 肖桂元, 周甘平, 等. MRSA感染用藥分析 [J]. 現代醫院, 2008; 8(10): 19-21. | 
				                                                        
				                                                            
				                                                                | 12. | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: Fifteenth informational supplement [S]. Wayne, Pa., 2005: M100-S15. | 
				                                                        
				                                                            
				                                                                | 13. | Gould FK, Brindle R, Chadwick PR, et al. Guidelines (2008) for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the United Kingdom [J]. J Antimicrob Chemother, 2009; 63(5): 849-861. | 
				                                                        
				                                                            
				                                                                | 14. | Ferrara AM. Treatment of hospital-acquired pneumonia cau-sed by methicillin-resistant Staphylococcus aureus [J]. Int J Antimicrob Agents, 2007; 30(1): 19-24. | 
				                                                        
				                                                            
				                                                                | 15. | Gould IM. MRSA bacteraemia [J]. Int J Antimicrob Agen-ts, 2007; 30 Suppl 1: S66-S70. |